| 2016 | | Desensitization Using Bortezomib and High-dose Immunoglobulin Increases Rate of Deceased Donor Kidney Transplantation | 정종철 |
| 2021 | | Determinants of quality of life in women immediately following the completion of primary treatment of breast cancer: A cross-sectional study | 김지영, 박진희, 배선형, 정용식 |
| 2016 | | Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas | 김성수, 서해영, 장다영 |
| 2022 | | Discovery of 3-Aminopyrazole Derivatives as New Potent and Orally Bioavailable AXL Inhibitors | 허훈 |
| 2017 | | Does the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor differ according to the type of EGFR mutation in non-small cell lung cancer? | 최용원, 최진혁 |
| 2000 | | Dual anticancer activity of 8-Cl-cAMP: inhibition of cell proliferation and induction of apoptotic cell death. | 이명애 |
| 2014 | | Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors. | 박준성, 정성현 |
| 2018 | | EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non-Small Cell Lung Cancer Patients | 강석윤, 고영화, 박준성, 신승수, 이현우, 정성현, 최용원, 최진혁, 한재호 |
| 2010 | | Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK. | 김철호, 이진석, 정연훈 |
| 2020 | | Evolution of Machine Learning Algorithms in the Prediction and Design of Anticancer Peptides | Balachandran, Manavalan, Basith, Shaherin, 신태환, 이광, 이다연 |
| 2016 | | Factors Influencing Posttraumatic Growth in Survivors of Breast Cancer | 박진희, 정용식 |
| 2018 | | Feasibility and accessibility of electronic patient-reported outcome measures using a smartphone during routine chemotherapy: a pilot study | 이현우 |
| 2017 | | Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results | 강석윤 |
| 2016 | | Feasibility of hyperthermic pressurized intraperitoneal aerosol chemotherapy in a porcine model | 손상용 |
| 2019 | | Gambogic acid triggers vacuolization-associated cell death in cancer cells via disruption of thiol proteostasis | 김인영, 최경숙 |
| 2017 | | Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma | 모정순 |
| 2021 | | Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: Radiologic and clinical factors predictive of survival | 권요한, 김재근, 김진우, 원제환, 조효정, 허지미 |
| 2021 | | High SLC2A1 expression associated with suppressing CD8 T cells and B cells promoted cancer survival in gastric cancer | 고영화 |
| 2017 | | Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenib | 김보현, 김순선, 김재근, 신성재, 양민재, 유병무, 이광재, 이기명, 이제희, 임선교, 정재연, 조성원, 조효정, 황재철 |
| 2015 | | Highlights of the Twelfth Japan-Korea Joint Symposium on Cancer and Ageing Research. | 박태준 |
| 2012 | | Histone deacetylase inhibitors induce mitochondrial elongation | 정선용 |
| 1998 | | Identification of diphtheria toxin via screening as a potent cell cycle and p53-independent cytotoxin for human prostate cancer therapeutics. | 임호영 |
| 2016 | | Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study | 박준성 |
| 2002 | | Imidazoline drugs stabilize lysosomes and inhibit oxidative cytotoxicity in astrocytes. | 박문성 |
| 2023 | | Impact of PARP inhibitor maintenance therapy in newly diagnosed advanced epithelial ovarian cancer: A meta-analysis | 손주혁, 장석준 |
| 2013 | | Influence of enzyme and transporter polymorphisms on trough imatinib concentration and clinical response in chronic myeloid leukemia patients. | 박준성 |
| 2012 | | Inhibition of Bcl-xL by ABT-737 enhances chemotherapy sensitivity in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumor cells | 김보영, 김현주, 임현이, 정선용, 진현석, 한재호 |
| 2012 | | Inhibition of COX-2 in colon cancer modulates tumor growth and MDR-1 expression to enhance tumor regression in therapy-refractory cancers in vivo | 김영배 |
| 2004 | | Inhibition of N-(4-hydroxyphenyl)retinamide-induced apoptosis in breast cancer cells by galectin-3. | 최진혁 |
| 2016 | | Late-acquired incomplete stent apposition after everolimus-eluting stent versus sirolimus-eluting stent implantation in patients with non-ST-segment elevation myocardial infarction and ST-segment elevation myocardial infarction | 최소연 |
| 2020 | | Loco-regional outcomes of adjusted breast radiotherapy with conventional fractionation after breast conserving surgery: De-escalation of whole breast irradiation dose | 노오규, 오영택, 전미선 |
| 2020 | | Long-term risk of congestive heart failure in younger breast cancer survivors: A nationwide study by the SMARTSHIP group | 한세환 |
| 2019 | | Loperamide overcomes the resistance of colon cancer cells to bortezomib by inducing CHOP-mediated paraptosis-like cell death | 최경숙, 최용원 |
| 2007 | | Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapy. | 강석윤, 강승희, 김장희, 김효철, 박준성, 신승수, 오영택, 이광재, 이현우, 전미선, 최진혁, 한재호 |
| 2011 | | Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy. | 박준성, 정성현 |
| 2019 | | mACPpred: A Support Vector Machine-Based Meta-Predictor for Identification of Anticancer Peptides | Balachandran, Manavalan, 이광 |
| 2023 | | Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3 | 공태욱 |
| 2019 | | Medical Treatment with Somatostatin Analogues in Acromegaly: Position Statement | 김대중 |
| 2014 | | MET expression is associated with disease-specific survival in breast cancer patients in the neoadjuvant setting. | 고영화 |
| 2006 | | Mitochondrial ligand inhibits store-operated calcium influx and COX-2 production in human microglia. | 김승업 |
| 2022 | | Mobile web-based self-management program for breast cancer patients with chemotherapy-induced amenorrhoea: A quasi-experimental study | 김지영, 박진희, 배선형, 정용식 |
| 2013 | | Monensin, a polyether ionophore antibiotic, overcomes TRAIL resistance in glioma cells via endoplasmic reticulum stress, DR5 upregulation and c-FLIP downregulation. | 임준희, 최경숙 |
| 2012 | | Nonsteroidal antiinflammatory drugs (NSAID) versus NSAID with hydroxychloroquine in treatment of chemotherapy-related arthropathy: open-label multicenter pilot study | 김현아, 서창희 |
| 2014 | | Nonthermal plasma induces head and neck cancer cell death: the potential involvement of mitogen-activated protein kinase-dependent mitochondrial reactive oxygen species. | 강성운, 김철호, 신유섭, 장재원 |
| 2014 | | Novel synthetic protective compound, KR-22335, against cisplatin-induced auditory cell death. | 강성운, 김철호, 신유섭 |
| 2017 | | Nutlin-3 enhances the bortezomib sensitivity of p53-defective cancer cells by inducing paraptosis | 김인영, 최경숙 |
| 2013 | | Oncologic outcomes after adjuvant chemotherapy using FOLFOX in MSI-H sporadic stage III colon cancer. | 김도윤, 김영배, 서광욱, 오승엽 |
| 2024 | | Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line Treatment of Advanced Gastric Cancer: K-Umbrella Gastric Cancer Study | 이현우 |
| 2017 | | Optimal radiation dose for patients with one to three lymph node positive breast cancer following breast-conserving surgery and anthracycline plus taxane-based chemotherapy: A retrospective multicenter analysis (KROG 1418) | 전미선 |
| 2020 | | Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09) | 안미선 |
| 2016 | | Paraptosis in the anti-cancer arsenal of natural products | 김인영, 최경숙 |
| 2011 | | Paxilline enhances TRAIL-mediated apoptosis of glioma cells via modulation of c-FLIP, survivin and DR5. | 최경숙 |
| 2010 | | Pediatric primary cutaneous marginal zone B-cell lymphoma treated with intralesional rituximab. | 김유찬, 박준은, 정현주 |
| 2019 | | Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers | 이진구 |
| 2019 | | Phase II study of R-CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study | 정성현 |
| 2012 | | Phase II trial of rituximab plus CVP combination chemotherapy for advanced stage marginal zone lymphoma as a first-line therapy: Consortium for Improving Survival of Lymphoma (CISL) study | 김효철 |
| 2013 | | Pipernonaline from Piper longum Linn. induces ROS-mediated apoptosis in human prostate cancer PC-3 cells. | 지재훈 |
| 2013 | | Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib. | 박준성, 정성현 |
| 2014 | | Prevention of cisplatin-induced ototoxicity by the inhibition of gap junctional intercellular communication in auditory cells. | 김연주, 임혜진, 전춘걸, 정연훈 |
| 2018 | | Procarbazine and CCNU Chemotherapy for Recurrent Glioblastoma with MGMT Promoter Methylation | 김세혁 |
